BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19578052)

  • 1. CDX2 expression in yolk sac component of testicular germ cell tumors.
    Bing Z; Pasha T; Tomaszewski JE; Zhang P
    Int J Surg Pathol; 2009 Oct; 17(5):373-7. PubMed ID: 19578052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of SOX2 and SOX17 in testicular germ cell tumors.
    Nonaka D
    Am J Clin Pathol; 2009 May; 131(5):731-6. PubMed ID: 19369635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDX-2 expression in malignant germ cell tumors of the testes, intratubular germ cell neoplasia, and normal seminiferous tubules.
    Lee MJ; Vogt AP; Hsiao W; Osunkoya AO
    Tumour Biol; 2012 Dec; 33(6):2185-8. PubMed ID: 22895825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDX2 immunostaining in primary and metastatic germ cell tumours of the testis.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    J Int Med Res; 2016 Dec; 44(6):1323-1330. PubMed ID: 28322096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors.
    Rougemont AL; Tille JC
    Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
    Cao D; Li J; Guo CC; Allan RW; Humphrey PA
    Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of CDX2, GATA3, and DOG1 in the diagnosis of testicular neoplasms: an immunohistochemical study of 109 cases.
    Osman H; Cheng L; Ulbright TM; Idrees MT
    Hum Pathol; 2016 Feb; 48():18-24. PubMed ID: 26772394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ cell tumors of the mediastinum and testis: a comparative immunohistochemical study of 120 cases.
    Suster S; Moran CA; Dominguez-Malagon H; Quevedo-Blanco P
    Hum Pathol; 1998 Jul; 29(7):737-42. PubMed ID: 9670832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncofetal protein glypican-3 in testicular germ-cell tumor.
    Ota S; Hishinuma M; Yamauchi N; Goto A; Morikawa T; Fujimura T; Kitamura T; Kodama T; Aburatani H; Fukayama M
    Virchows Arch; 2006 Sep; 449(3):308-14. PubMed ID: 16896894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Somatic-type" malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin.
    Magers MJ; Kao CS; Cole CD; Rice KR; Foster RS; Einhorn LH; Ulbright TM
    Am J Surg Pathol; 2014 Oct; 38(10):1396-409. PubMed ID: 24921638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Mediastinal Yolk Sac Tumors: An Immunohistochemical Analysis of 14 Cases.
    Weissferdt A; Kalhor N; Rodriguez Canales J; Fujimoto J; Wistuba II; Moran CA
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):125-133. PubMed ID: 27643524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase II alpha expression in testicular germ cell tumors.
    Dimov ND; Zynger DL; Luan C; Kozlowski JM; Yang XJ
    Urology; 2007 May; 69(5):955-61. PubMed ID: 17482942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
    Cao D; Guo S; Allan RW; Molberg KH; Peng Y
    Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of OCT4 in the primary germ cell tumors and thymoma in the mediastinum.
    Jung SM; Chu PH; Shiu TF; Wu HH; Kuo TT; Chu JJ; Lin PJ
    Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):273-5. PubMed ID: 16932017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors.
    Gonzalez-Roibon N; Katz B; Chaux A; Sharma R; Munari E; Faraj SF; Illei PB; Torbenson M; Netto GJ
    Hum Pathol; 2013 Jul; 44(7):1293-9. PubMed ID: 23347651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms.
    Yu H; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):767-75. PubMed ID: 17951198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17.
    Zhou Y; Rothrock A; Murugan P; Li F; Bu L
    Exp Mol Pathol; 2022 Jun; 126():104761. PubMed ID: 35390309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically atypical seminomas with yolk sac tumor features.
    Som A; Xiao L; Zhu R; Guo CC; Xiao L; Rao P; Efstathiou E; Matin A; Tu SM
    Can J Urol; 2013 Aug; 20(4):6860-7. PubMed ID: 23930614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors.
    Gallo A; Fankhauser C; Hermanns T; Beyer J; Christiansen A; Moch H; Bode PK
    Mod Pathol; 2020 Nov; 33(11):2354-2360. PubMed ID: 32561848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostaining of stage-specific embryonic antigen-4 in intratubular germ cell neoplasia unclassified and in testicular germ-cell tumors.
    Tokuyama S; Saito S; Takahashi T; Ohyama C; Ito A; Kanto S; Satoh M; Hoshi S; Endoh M; Arai Y
    Oncol Rep; 2003; 10(5):1097-104. PubMed ID: 12883664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.